Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence

Sponsor
Chulalongkorn University (Other)
Overall Status
Completed
CT.gov ID
NCT03258190
Collaborator
Sanpasitthiprasong Hospital (Other), Burapha University (Other)
137
1
2
48
2.9

Study Details

Study Description

Brief Summary

Lime powder regimen (LPR) is a lime-derived composition enriches with citrate/citric acid and potassium. LPR was invented to treat the renal stone patients with high risk of stone recurrence after stone removal. LPR should have equal or higher efficacy and lower adverse effect than current standard medicine.

Condition or Disease Intervention/Treatment Phase
  • Drug: Lime Powder Regimen
Phase 2

Detailed Description

Lime powder regimen (LPR) is a mixture of lime-derive component with adjuvants containing high concentration of citrate, and moderate amount of potassium, magnesium and antioxidants. LPR was tested and verified to be very less toxic in cell culture and animal models. The clinical trial phase II showed that LPR reduced urinary metabolic abnormalities that enhance stone formation, such as hypocitraturia, hypokaliuria and acidified urine. Adverse effect of LPR was very low.

Study Design

Study Type:
Interventional
Actual Enrollment :
137 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized control trialRandomized control trial
Masking:
Single (Participant)
Masking Description:
LPR and Placebo were prepared in the same containers with code that was provided by investigators
Primary Purpose:
Prevention
Official Title:
Lime Powder Regimen Supplement Alleviates Urinary Metabolic Abnormalities to Prevent Urolithiasis Recurrence.
Actual Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Jun 1, 2018
Actual Study Completion Date :
Jun 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lime Powder Regimen

Participants were asked to take LPR twice a day for 6 months

Drug: Lime Powder Regimen
LPR and placebo were randomly given to subjects for 6 months
Other Names:
  • LPR supplement
  • Placebo Comparator: Placebo

    Participants were asked to take Placebo twice a day for 6 months

    Drug: Lime Powder Regimen
    LPR and placebo were randomly given to subjects for 6 months
    Other Names:
  • LPR supplement
  • Outcome Measures

    Primary Outcome Measures

    1. Renal stone recurrence [6 months]

      The stone recurrence after surgical removal of stone that can be detected by CT scan

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Renal stone patients who were identified and stone was removed by surgical method.
    Exclusion Criteria:
    • Chronic kidney disease, chronic liver disease, history of coronary artery disease, or person who takes any medication that alters urinary metabolic profiles

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Chulalongkorn University Bangkok Thailand 10330

    Sponsors and Collaborators

    • Chulalongkorn University
    • Sanpasitthiprasong Hospital
    • Burapha University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Piyaratana Tosukhowong, Professor, Chulalongkorn University
    ClinicalTrials.gov Identifier:
    NCT03258190
    Other Study ID Numbers:
    • LPR0001
    First Posted:
    Aug 23, 2017
    Last Update Posted:
    Feb 1, 2019
    Last Verified:
    Jan 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Piyaratana Tosukhowong, Professor, Chulalongkorn University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 1, 2019